AbbVie’s $10.9 Billion Apogee Deal Puts a Price on the Next Immunology Race
AbbVie's $10.9 billion deal for Apogee Therapeutics shows how aggressively big pharma is paying to protect its next immunology growth cycle.
Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
AbbVie's $10.9 billion deal for Apogee Therapeutics shows how aggressively big pharma is paying to protect its next immunology growth cycle.
Continuous Coverage
Germany advanced to the World Cup knockout stage against Ivory Coast, but Nico Schlotterbeck's ankle-ligament injury has quickly…
For nearly two decades he was the most powerful economic figure in Washington, hailed as the Maestro before…
New York State opened a formal study on June 22, 2026, into whether New York City and Lake…
Keir Starmer said on June 22, 2026, that he will resign as Britain\s prime minister and Labour leader,…
Earth crosses comet 7P/Pons-Winnecke's uneven debris this week. Most years the June Bootids barely show; in 1998 they…
Alberto Carvalho resigned from LAUSD on June 21, leaving acting superintendent Andrés Chait to stabilize the second-largest U.S.…
Global Affairs
France widened its top heat alert to 49 departments on Monday, June 22, 2026, as schools closed, nights…
Markets And Money
A blast at Qatar's Barzan gas facility left 54 injured and 18 missing, exposing how fragile Gulf gas…
Digital Culture
John Jumper, the AlphaFold co-creator who shared the 2024 Nobel Prize in Chemistry, said on June 20, 2026…
Science And Wellbeing
Health officials in Maryland, Virginia, and Washington, D.C., issued overlapping measles alerts tied to Washington Dulles International Airport…
Screen And Sound
Toy Story 5 opened to $160 million in North America for a $312 million global launch, the biggest…
Fixtures And Form
Wyndham Clark turned a six-shot final-round cushion into a one-shot survival act at Shinnecock Hills, beating Sam Burns…